Osteoarthritis

Musculoskeletal·MeSH: Osteoarthritis

Prevalence

10000.0 / 100K

Incidence

600.0 / 100K/yr

74 drugs in development·39 companies·31 clinical trials

Drug Pipeline by Phase

Approved(23)

Drug	Company
celecoxib	Aptinyx Inc. (APTX)
celecoxib	Zomedica Corp. (ZOMDF)
celecoxib	ACADIA PHARMACEUTICALS INC (ACAD)
celecoxib	AlphaTON Capital Corp (ATON)
celecoxib	Miromatrix Medical Inc. (MIRO)
Cymbalta®	ELI LILLY & Co (LLY)
diclofenac	SUNSET ISLAND GROUP (SUN)
diclofenac	Aptinyx Inc. (APTX)
diclofenac	Miromatrix Medical Inc. (MIRO)
galliprant	ARATANA THERAPEUTICS, INC. (PETX)
genvisc	Avanos Medical Inc. (AVNS)
indocin	Assertio Holdings, Inc. (ASRT)
indocin	Zyla Life Sciences (ZCOR)
INDOCIN (suppositories and oral suspension)	Assertio Holdings, Inc. (ASRT)
INDOCIN Oral Suspension	Assertio Holdings, Inc. (ASRT)
indomethacin	Amneal Pharmaceuticals, Inc. (AMRX)
indomethacin	Mylan II B.V. (MYL)
inFoods® (IBS)	BIOMERICA INC (BMRA)
meloxicam	Mylan II B.V. (MYL)
vivlodex	Zyla Life Sciences (ZCOR)
zilretta	Flexion Therapeutics Inc (FLXN)
ZILRETTA	Pacira BioSciences, Inc. (PCRX)
zorvolex	Zyla Life Sciences (ZCOR)

Phase 3(12)

Drug	Company
Apitox (Apitoxin in South Korea)	Apimeds Pharmaceuticals US, Inc. (APUS)
Eloralintide	ELI LILLY & Co (LLY)
Ketorolac	Clearside Biomedical, Inc. (CLSDQ)
lorecivivint	TG THERAPEUTICS, INC. (TGTX)
Platelet Rich Plasma Injection	UNITED THERAPEUTICS Corp (UTHR)
plx-pad	Pluri Inc. (PLUR)
ptp-01	Horizon Therapeutics Public Ltd Co (HZNP)
ranevetmab	Nexvet Biopharma plc (NVET)
tlc599	Endo International plc (ENDP)
Triamcinolone	Valneva SE (VALN)
zilretta	West Pharmaceutical Services Inc. (WST)
ZILRETTA (shoulder indication)	Pacira BioSciences, Inc. (PCRX)

Phase 2(24)

Drug	Company
[prp] platelet rich plasma	HWH International Inc. (HWH)
[stromed + platelet rich plasma]	HWH International Inc. (HWH)
ACP-044 Dose A	ACADIA PHARMACEUTICALS INC (ACAD)
ACP-044 Dose B	ACADIA PHARMACEUTICALS INC (ACAD)
allocetra	Enlivex Ltd. (ENLV)
allojoin	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
dfv890	Novartis AG (NVS)
enekinragene inzadenovec	ACURA PHARMACEUTICALS, INC (ACUR)
frunevetmab	Nexvet Biopharma plc (NVET)
lna043	NOVARTIS AG (NVSEF)
lna043	Novartis AG (NVS)
LY3016859 ISA	ELI LILLY & Co (LLY)
LY3526318 ISA	ELI LILLY & Co (LLY)
LY3556050 ISA	ELI LILLY & Co (LLY)
LY3857210 ISA	ELI LILLY & Co (LLY)
LY4065967	ELI LILLY & Co (LLY)
PIPE-307	Contineum Therapeutics, Inc. (CTNM)
PIPE-791	Contineum Therapeutics, Inc. (CTNM)
quc398	Novartis AG (NVS)
quc398	NOVARTIS AG (NVSEF)
rejoin	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
resiniferatoxin	Sorrento Therapeutics, Inc. (SRNE)
rhh646	Novartis AG (NVS)
RHH646	Novartis AG (NVS)

Phase 1(4)

Drug	Company
allogeneic engineered gingival fibroblasts	TG THERAPEUTICS, INC. (TGTX)
dfv890	Novartis AG (NVS)
fx201	Flexion Therapeutics Inc (FLXN)
sar446959	Sanofi (SNY)

Preclinical(3)

Drug	Company
AR-300	Ampio Pharmaceuticals, Inc. (AMPE)
epoladerm	Virpax Pharmaceuticals, Inc. (VRPX)
OA-201	Ampio Pharmaceuticals, Inc. (AMPE)

Unknown(2)

Drug	Company
Ampion®	Ampio Pharmaceuticals, Inc. (AMPE)
InFoods® platform (other disease targets)	BIOMERICA INC (BMRA)

Phase 4(6)

Drug	Company
Botulinum Toxin A	Revance Therapeutics, Inc. (RVNC)
Injection of triamcinolone acetonide into the CMC-1 joint	Cidara Therapeutics, Inc. (CDTX)
Ketorolac Injection	UNITED THERAPEUTICS Corp (UTHR)
Ketorolac Injection	Valneva SE (VALN)
onabotulinumtoxin A	Revance Therapeutics, Inc. (RVNC)
OnabotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 74 drugs in development for Osteoarthritis across 39 companies.

There are 31 clinical trials targeting Osteoarthritis tracked by BioSniper.

The estimated prevalence of Osteoarthritis is approximately 10000.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.